Industry Buzz: Cologuard’s Wild September Ride

The month of September has been a rollercoaster for a product that has in many ways become the face of the consumer genetic testing market, Exact Sciences’ Cologuard. The Growth of Cologuard … [Read more...]

FDA WATCH

Emerging Tests: FDA Breaks New Ground by Clearing EIA Technology-Based Lyme Assays

Laboratory diagnosis of Lyme disease is based on detecting the presence of antibodies against Borrelia burgdorferi, the bacteria that causes the disease, in a patient's blood. Traditional testing uses … [Read more...]

INSIDE THE INDUSTRY

Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test

Few of the newfangled consumer genetic testing products have had greater commercial success and visibility than Exact Science's Cologuard colorectal cancer screening test. But a troubling new … [Read more...]

EMERGING TESTS

Study Finds Liquid Biopsies More Effective than Traditional Biopsies in Detecting Cancer Drug Resistance

Liquid biopsies based on blood samples do a better job than traditional biopsies in analyzing both the genetic diversity of the patient's cancer and how tumors evolve drug resistance at the molecular … [Read more...]

INNOVATION

Point of Care: Handheld Device Shows Promise in Detecting Concussion from Blood Samples

A handheld portable device could be more effective than a CT scan in detecting mild traumatic brain injuries (TBI), according to a new study published in The Lancet Neurology. Because it is capable of … [Read more...]

EMERGING TESTS

Inside the Industry: Government Report Casts Doubt on Cost-Effectiveness of Leading Genetic Colorectal Cancer Screening Test

Few of the newfangled consumer genetic testing products have had greater commercial success and visibility than Exact Science's Cologuard colorectal cancer screening test. But a troubling new … [Read more...]

GENETIC TESTING

Genetic Testing: Multigene Panel Testing Detects Hereditary Risk Variants in Metastatic Breast Cancer Patients

The clinical value of performing multigene panel for inherited cancer in patients with metastatic breast cancer has been the subject of considerable debate. Those who believe in the value of such … [Read more...]

INDUSTRY TRENDS

Adoption Quickening for Genomic Cancer Testing in Community Settings

Clinicians are increasingly using genomic cancer testing in community health care settings, although there are lingering questions about the utility of results. These are the findings of several … [Read more...]

EMERGING TESTS

Top of the News: Early Results Show Blood Test’s Effectiveness in Early Alzheimer’s Detection

Developing a cost-effective blood test capable of accurately detecting early Alzheimer's disease that can be furnished at a doctor's office has been a goal for decades. And now comes word that … [Read more...]

EMERGING TESTS

Nonculture Molecular Tests Speed Diagnosis of Bloodstream Infections

The T2Bacteria Panel (T2Biosystems; Lexington, Mass.) can rapidly and accurately diagnoses bloodstream infections (BSIs) caused by five common bacteria, according to a study published May 14 in the … [Read more...]


(-00000g2)